Clinical Trial: A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357831) titled 'A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects' on Dec. 11, 2025.

Brief Summary: This is a multi-center, randomized, investigator-blinded, calcipotriol and betamethasone dipropionate gel and vehicle-controlled phase 3 clinical study to evaluate the efficacy and safety of MC2-01 cream in the treatment of Chinese plaque psoriasis to assess the efficacy and safety of MC2-01 cream in Chinese subjects aged >= 18 years with plaque psoriasis. This study includes a screening period, a treatment period, and a safety follow-up period.

Study Start Date: Ja...